ResMed Inc.
RMD NYSEHealthcare ★★★★★Latest Earnings
Date
Aug 6, 2026
ET
EPS Est.
2.89
EPS Actual
2.95
Revenue Est.
$1.46B
Revenue Actual
$1.46B
Next Earnings Report
Date
Oct 29, 2026 · Thu
Time
After-market
Fiscal Period
FY2027 Q1
EPS Est.
2.69
Revenue Est.
$1.39B
Company Overview
ResMed Inc. (ticker RMD) is listed on NYSE with a market cap of about $33.58B. Its next earnings report (FY2027 Q1) is expected on Oct 29, 2026 (ET), After-market, with consensus EPS of 2.69. In the last 15 reported quarters, EPS beat consensus estimates 12 times.
Actual EPS TrendRecently15Term · Jan 26, 2023 → Aug 6, 2026
Jan 26, 2023Range: 1.60 ~ 2.95Aug 6, 2026
Earnings History
| Date | Fiscal Period | EPS Est. | EPS Actual | Revenue Est. | Revenue Actual |
|---|---|---|---|---|---|
| Aug 6, 2026 | -- | 2.89 | 2.95 | $1.46B | $1.46B |
| Apr 30, 2026 | -- | 2.80 | 2.86 | $1.42B | $1.43B |
| Jan 29, 2026 | -- | 2.74 | 2.81 | $1.4B | $1.42B |
| Oct 30, 2025 | -- | 2.51 | 2.55 | $1.33B | $1.34B |
| Jul 31, 2025 | -- | 2.55 | 2.55 | $1.35B | $1.35B |
| Apr 23, 2025 | -- | 2.38 | 2.37 | $1.29B | $1.29B |
| Jan 30, 2025 | -- | 2.32 | 2.43 | $1.27B | $1.28B |
| Oct 24, 2024 | -- | 2.04 | 2.20 | $1.19B | $1.22B |
| Aug 1, 2024 | -- | 2.07 | 2.08 | $1.22B | $1.22B |
| Apr 25, 2024 | -- | 1.91 | 2.13 | $1.17B | $1.2B |
| Jan 24, 2024 | -- | 1.81 | 1.88 | $1.15B | $1.16B |
| Oct 26, 2023 | -- | 1.62 | 1.64 | $1.1B | $963M |
| Aug 3, 2023 | -- | 1.69 | 1.60 | $1.14B | $1.12B |
| Apr 27, 2023 | -- | 1.59 | 1.68 | $1.13B | $1.12B |
| Jan 26, 2023 | -- | 1.62 | 1.66 | $996.1M | $1.03B |
Original Filings (SEC)
8-K2026-08-17 ↗
10-K2026-08-13 ↗
8-K2026-08-06 ↗
8-K2026-07-07 ↗
10-Q2026-05-01 ↗
8-K2026-04-30 ↗
8-K2026-04-30 ↗
10-Q2026-01-30 ↗
Links point to the company's original filings on the U.S. Securities and Exchange Commission (SEC) website.
Report dates are US trading days (Eastern Time); EPS and revenue estimates are market consensus, in USD. This page is for reference only and does not constitute investment advice.
